Cascade Biologics Incorporated Company Profile

05:16 EDT 20th September 2017 | BioPortfolio

Cascade Biologics, Inc. cells, media, growth supplements and reagents for biomedical research.


4475 SW Scholls Ferry RoadSuite 201
United States of America


Phone: 503 292 9521
Fax: 503 292 0566

News Articles [627 Associated News Articles listed on BioPortfolio]

Signal transduction in a covalent post-assembly modification cascade

Two coordination cages have been devised that undergo covalent modification during a cascade of two orthogonal Diels–Alder reactions. This results in increased lipophilicity for the second cage, ena...

Structural biology: Cascade keeps its targets in the loop

This study presents cryo-electron microscopy structures of the type I-E Cascade and provides insights into PAM-dependent R-loop formation, Cas3 recruitment and substrate handover.

Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing

This JAMA Insights article explains process of cascade screening for familial hypercholesterolemia and its efficacy in reducing risk of atherosclerotic cardiovascular disease.

Seattle Genetics Discontinues Phase 3 CASCADE Trial In Frontline AML

WASHINGTON (dpa-AFX) - Seattle Genetics Inc. (SGEN) said that it discontinued the phase 3 CASCADE clinical trial of vadastuximab talirine or SGN-CD33A in frontline older acute myeloid leukemia or ...

Water Purification System

Product AnnouncementLabStrong Corporation is now offering the Cascade Type II DI water purification system. The new Cascade system is offered in two different configurations. The first is the Quad sty...

Publication of the Securities Note Having Obtained Visa No. 17-297 of the AMF in Connection with the Capital Increase of GenSight Biologics

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA AND JAPAN. Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), ("GenSight Biologics...

Heat Biologics, Inc.: Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics

DURHAM, NC / ACCESSWIRE / July 3, 2017 / Heat Biologics, Inc. ("Heat") (Nasdaq: HTBX), a leader in the development of novel therapies designed to activate a patient's immune system against cancer, ...

A CASCADE Of Trouble For Seattle Genetics' AML Drug SGN-CD33A

Seattle Genetics will discontinue all trials of vadastuximab talrine, including the Phase III CASCADE trial in frontline older acute myeloid...   

PubMed Articles [402 Associated PubMed Articles listed on BioPortfolio]

New biologics in psoriasis: an update on IL-23 and IL-17 inhibitors.

As immune-related pathways involved in the pathogenesis of psoriasis are elucidated, new biologic treatments targeting these steps of the psoriatic immune cascade are developed. In this article, we re...

Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Biologic disease-modifying anti-rheumatic drugs (DMARDs: referred to as biologics) are effective in treating rheumatoid arthritis (RA), however there are few head-to-head comparison studies. Our syste...

Prolongation of biologic dosing intervals in patients with stable psoriasis: a feasibility study.

Biologics are usually licensed according to the "one dose fits all" principle. It is therefore suspected that a significant number of psoriasis patients are overtreated. However, evidence for successf...

Biosimilars: biologics that meet patients' needs and healthcare economics.

Biologics have revolutionized medical care, yet uniform access to these effective medicines remains difficult due to the increasing costs of healthcare. As patent exclusivity on the early biologics wa...

The expanding field of biologics in the management of chronic urticaria.

Chronic urticaria (CU) is the occurrence of urticaria with or without angioedema for at least 6 weeks. Management has traditionally involved antihistamines as first-line therapy with various alternati...

Clinical Trials [135 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Companies [293 Associated Companies listed on BioPortfolio]

Cascade Biologics Incorporated

Cascade Biologics, Inc. cells, media, growth supplements and reagents for biomedical research.

Cascade Biologics, Inc.


Cascade TEK

Since 1992, Cascade TEK has provided drying solutions for military, aerospace, medical and automotive industries. Our forced air laboratory and vacuum ovens are made in the USA. C...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

More Information about "Cascade Biologics Incorporated" on BioPortfolio

We have published hundreds of Cascade Biologics Incorporated news stories on BioPortfolio along with dozens of Cascade Biologics Incorporated Clinical Trials and PubMed Articles about Cascade Biologics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cascade Biologics Incorporated Companies in our database. You can also find out about relevant Cascade Biologics Incorporated Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record